WEIL JOHN D 4
4 · ALLIED HEALTHCARE PRODUCTS INC · Filed Nov 30, 2021
Insider Transaction Report
Form 4
WEIL JOHN D
Director10% Owner
Transactions
- Sale
Common Stock
2021-11-26$8.06/sh−7,514$60,537→ 0 total(indirect: Corporation) - Award
Option to purchase common stock
2021-11-11+750→ 750 totalExercise: $5.09From: 2022-11-11Exp: 2031-11-11→ Common stock (750 underlying) - Sale
Common Stock
2021-11-26$8.44/sh−69,249$584,254→ 25,178 total(indirect: By Spouse) - Sale
Common Stock
2021-11-26$8.47/sh−59,101$500,408→ 0 total(indirect: By Trust)
Holdings
- 53,810(indirect: By Trust)
Common Stock
- 750
Option to purchase common stock
Exercise: $2.34From: 2016-11-12Exp: 2025-11-12→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $1.17From: 2020-11-07Exp: 2029-11-07→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $7.86From: 2021-11-12Exp: 2030-11-12→ Common stock (750 underlying) - 2,500(indirect: By IRA)
Common Stock
- 750
Option to purchase common stock
Exercise: $5.18From: 2013-11-08Exp: 2022-11-08→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $4.62From: 2014-11-14Exp: 2023-11-14→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $3.16From: 2015-11-13Exp: 2024-11-13→ Common stock (750 underlying) - 90,513
Common Stock
- 750
Option to purchase common stock
Exercise: $2.26From: 2017-11-10Exp: 2026-11-10→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $2.22From: 2018-11-09Exp: 2027-11-09→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $2.13From: 2019-11-08Exp: 2028-11-08→ Common stock (750 underlying)
Footnotes (6)
- [F1]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The reporting person disclaims any economic benefit in such shares.
- [F3]Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
- [F4]Owned by a corporation controlled by the reporting person.
- [F5]Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares. The decrease of 6,710 reported shares between the amount reported in this filing and the amount reported in the most recent previous filing is due to omission of a trust for which the reporting person no longer serves as trustee and with respect to which the reporting person no longer has any pecuniary interest.
- [F6]Issued pursuant to the Company's 2013 Director's Stock Option Plan.